Tissue suction-mediated gene transfer to the beating heart in mice

PLoS One. 2020 Feb 6;15(2):e0228203. doi: 10.1371/journal.pone.0228203. eCollection 2020.

Abstract

We previously developed an in vivo site-specific transfection method using a suction device in mice; namely, a tissue suction-mediated transfection method (tissue suction method). The aim of this study was to apply the tissue suction method for cardiac gene transfer. Naked plasmid DNA (pDNA) was intravenously injected in mice, followed by direct suction on the beating heart by using a suction device made of polydimethylsiloxane. We first examined the effects of suction conditions on transgene expression and toxicity. Subsequently, we analyzed transgene-expressing cells and the transfected region of the heart. We found that heart suction induced transgene expression, and that -75 kPa and -90 kPa of suction achieved high transgene expression. In addition, the inner diameter of the suction device was correlated with transgene expression, but the pressure hold time did not change transgene expression. Although the tissue suction method at -75 kPa induced a transient increase in the serum cardiac toxicity markers at 6 h after transfection, these markers returned to normal at 24 h. The cardiac damage was also analyzed through the measurement of hypertrophic gene expression, but no significant differences were found. In addition, the cardiac function monitored by echocardiography remained normal at 11 days after transfection. Immunohistochemical analysis revealed that CD31-positive endothelial cells co-expressed the ZsGreen1-N1 reporter gene. In conclusion, the tissue suction method can achieve an efficient and safe gene transfer to the beating heart in mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Creatine Kinase, MB Form / blood
  • Dimethylpolysiloxanes / chemistry
  • Echocardiography
  • Gene Expression
  • Heart / physiology*
  • Mice
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Myosin Heavy Chains / genetics
  • Myosin Heavy Chains / metabolism
  • Plasmids / administration & dosage
  • Plasmids / genetics
  • Plasmids / metabolism
  • Pressure
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / genetics
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Transfection / instrumentation
  • Transfection / methods*
  • Transgenes / genetics*
  • Troponin T / blood

Substances

  • Dimethylpolysiloxanes
  • Troponin T
  • baysilon
  • Creatine Kinase, MB Form
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Myosin Heavy Chains

Grants and funding

This work was partly supported by JSPS KAKENHI (Grant Number JP17K19496) and a Health and Labour Sciences Research Grant for Research on Medical Device Development (No. H24-009 to K.S.) from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.